← Eichor
Study identifier: NCT04945369 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Follow-up During the Peripubertal Period of Preterm Children Included in the Protocol Entitled "EPIPOD".

Condition: Preterm Children  ·  Sponsor: Nantes University Hospital

PhaseNA
Planned participants114
Who can joinAll sexes, 8 Years to 14 Years
Healthy volunteersNo

About this study

Prematurity is associated with an increased risk of developing cardiovascular and metabolic disturbances in adulthood. It has been demonstrated that the body composition of children born prematurely is different from that of children born under term with a deficit in fat free mass. It can thus be wondered if this excessive adiposity does or does not predict the risk of insulin resistance in adulthood. Children born prematurely, with a body composition measurement performed at discharge from neonatal hospitalization as part of the EPIPOD protocol, and now aged between 8 and 14 years, will be included in the INFANTPOD protocol. Analysis of body composition, insulin resistance, renal function, pulse wave velocity, eating behaviour and of physical activity will be performed.

This description comes directly from the study's public registry record.

Talk to the study team

Anne FRONDAS, Doctor  ·  +33 2 40 08 34 83  ·  anne.frondas@chu-nantes.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Nantes University HospitalNantes, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04945369